Upcoming Webinar

Scientific Update on IBS, IBD and the Gut Microbiota

Thursday, October 8th, 2020

Time: 8 p.m. (Vienna) / 8 p.m. (Cairo) / 9 p.m. (Amman) / 10 p.m. (Dubai)

Register now

Speakers Overview

Dr. Ahmed M. Hashim

EGYPT

Dr. Francisco Guarner

SPAIN

Dr. Alexander R Moschen

AUSTRIA

Dr. Alexander R Moschen (AUSTRIA)

Biography

Dr. Moschen graduated in 2004 from the Medical University Innsbruck, Austria with an intercalated MD thesis on the RANK/RANKL/OPG system in inflammatory bowel diseases. Three years of postdoctoral training were received in Professor Tilg’s Gastroenterology Research Laboratory in Innsbruck. Subject of Dr. Moschen’s PhD thesis was the impact of adipose tissue-derived mediators (adipocytokines) on leukocyte biology. He completed his clinical training in Internal Medicine at the University Hospital Innsbruck. After passing his board exams, he accepted a 12 months Senior Clincial Fellowship in Gastroenterology and Endoscopy at the Division of Gastroenterology of the Department of Medicine of the University of Cambridge (UK) in January 2012. Returning to Innsbruck in 2013, Dr. Moschen completed his specialty training in Gastroenterology and Hepatology and started his own research group. Here they investigate the mechanisms that underlie inflammation at the intestinal mucosal surface and particularly pathways that maintain a mutualistic relationship between the most complex and densely populated habitat of the microbiota and the intestinal immune systems. To address these questions, they are engaging animal models of intestinal inflammation in genetically modified animals in combination with quantitative biochemical and imaging approaches and they hold a comprehensive human biobank in IBD under valid ethical approval.

Positions

  • Assistant Professor of Medicine and Senior Scientist, Medical University Innsbruck
  • Head of Christian Doppler Research Laboratory for Mucosal Immunology
  • Reviewer for: Gastroenterology, Hepatology, Gut, Journal of Hepatology, Am J Gastroenterology, PlosOne, SFP, etc.
  • Member of: European Crohn’s Colitis Organisation, ÖGGH, ÖGIM, Austrian Microbiome Initiative

Research interest

Host pathogen interaction at the epithelial border of the gastrointestinal mucosal border, mechanisms involved in homeostasis, inflammation and tissue regeneration and repair.

Accolades

  • Paracelsus award (2016)
  • Otto-Kraupp award for Austria’s prime medical habilitation 2013 (2014)
  • Rising Star Award of the United European Gastroenterology (2014)
  • Sanofi-aventis award (2011)

Topic

The Gut-Brain Axis in IBS: Mechanisms and Therapeutic Targets

Dr. Francisco Guarner (SPAIN)

Biography

Professor Francisco Guarner graduated in Medicine at the University of Barcelona, Spain, in 1973. He trained in Internal Medicine, Gastroenterology and Hepatology at the Hospital Clinic in Barcelona with Professor Joan Rodes and at the University Clinic of Navarra (Spain) with Professor Jesus Prieto. His Ph.D. degree in Medicine was obtained at the University of Navarra in 1983 for his research studies on liver cell cytoprotection with prostaglandins. He has been Visiting Scientist and Research Fellow at the Upjohn Company in Kalamazoo (Michigan, USA, 1983), the Royal Free Hospital (London, UK, 1984), the King’s College Hospital (London, UK, 1984-1986), and the Wellcome Research Laboratories (Beckenham, UK, 1986). He joined the Digestive System Research Unit at the Hospital Vall d’Hebron (Barcelona) in 1987. Professor Francisco Guarner is currently Consultant of Gastroenterology at the Digestive System Research Unit and Head of the Experimental Laboratory at the University Hospital Vall d’Hebron (Barcelona). He is co-author of 300 publications on original research or reviews, in the field of mucosal immunity, gastrointestinal inflammation and gut microbiota.

Positions

  • Consultant of Gastroenterology at the Digestive System Research Unit and Head of the Experimental Laboratory at the University Hospital Vall d’Hebron (Barcelona).
  • Former President of the Board of the Spanish Society for Probiotics and Prebiotics.
  • Member of the Scientific Committee of the Research Institution of University Hospital Vall d’Hebron (www.vhir.org), Board of Directors of the International Scientific Association for Probiotics and Prebiotics (www.ISAPP.net) and the Steering Committee of the International Human Microbiome Consortium (IHMC, www.humanmicrobiome.org)

Research interest

Intestinal mucosa, ulcerative colitis, inflammatory bowel disease and probiotics.

Accolades

  • Honorary Member of the Spanish Society of Gastroenterology
  • Fellow of the American Gastroenterological Association

Topic

Gut Microbiome and Immunity

Dr. Ahmed Morad Hashim (Egypt)

Biography

Professor of Internal Medicine and Hepato-Gastroenterologist at the Kasr Al-Aini school of Medicine, Cairo University, Egypt

Positions

  • Consultant of Internal Medicine in Saudi Arabia
  • Consultant of Internal Medicine GI – Hepatology – GI Endoscopy in King Hammad University Hospital
  • Professor of Internal Medicine, GI – Hepatology in Royal College of Ireland RCSI Bahrain
  • Professor of Internal Medicine, GI – Hepatology in Arab Gulf University
  • Consultant Endoscopic ultrasound EUS and advanced Gastroenterology
  • 35 international and national Publication in a respectable Medical Journal
  • Member of editorial board of Egyptian Journal of Internal Medicine
  • Member of the administrative board of the Egyptian Society of Internal Medicine
  • Professor of Internal Medicine 6th October University
  • Professor of Internal Medicine in Cairo University

Topic

IBD - IBS ......... 1, 2 or 3 Diseases